Isonipecotamide CAS 39546-32-2

Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of isonipecotamide cas 39546-32-2 in China. Welcome to wholesale bulk high quality isonipecotamide cas 39546-32-2 for sale here from our factory. Good service and reasonable price are available.

Isonipecotamide, also known as 3-piperidinecarboxamide or homopiperidine-3-carboxamide, is a chemical compound belonging to the amide class. It is a derivative of isonipecotic acid, where the carboxylic acid group (-COOH) has been replaced by an amide group (-CONH2). This structural modification often alters the physicochemical properties and biological activities of the original compound.

In terms of its physical characteristics, it is typically a white or colorless crystalline solid. It is soluble in polar solvents such as water and alcohol, making it suitable for various applications in the chemical and pharmaceutical industries.

Chemically, it can undergo various reactions due to the presence of its amine and amide functionalities. These reactions include acetylation, alkylation, and reduction, among others, allowing for the synthesis of a wide range of derivatives with potential biological activities.

Biologically, it and its derivatives have shown some interesting pharmacological properties. For instance, certain analogs have been investigated for their potential as central nervous system (CNS) depressants or muscle relaxants. However, further research is needed to fully understand and exploit the therapeutic potential of this compound and its derivatives.

Overall, it represents a versatile chemical scaffold with potential applications in both the chemical synthesis and pharmaceutical fields. Its unique structural features and biological activities make it an attractive target for further research and development.

Although not directly used as a therapeutic agent itself, its derivatives or related compounds may exhibit pharmacological activities, such as anti-emetic or other potential therapeutic effects. Research into its biological activities may lead to the discovery of new drugs.

This is a specific example of a pharmaceutically active compound that is structurally related to isonipecotamide. It contains a piperidine ring with a carboxamide group and additional substituents that confer specific pharmacological properties, such as antiemetic activity.

Metopimazine is an antipsychotic medication belonging to the piperazine derivative class, primarily used in the treatment of various psychotic disorders, including schizophrenia. It works by modulating the activity of neurotransmitters, particularly dopamine and serotonin, in the brain. This modulation helps to alleviate symptoms such as hallucinations, delusions, disorganized thinking, and agitation, which are characteristic of psychotic conditions.

The drug exhibits both antipsychotic and anti-anxiety effects, making it a valuable option for patients experiencing both psychotic and anxiety-related symptoms. However, its exact mechanism of action is still partially understood, and further research is ongoing to elucidate its full pharmacological profile.

Metopimazine is typically prescribed in tablet form and should be taken as directed by a healthcare provider. The dosage may vary depending on the individual's condition, age, and response to treatment. It is essential to follow the prescribed regimen closely to ensure optimal therapeutic outcomes and minimize potential side effects.

Common side effects associated with metopimazine may include drowsiness, dizziness, blurred vision, dry mouth, and constipation. More severe side effects, such as extrapyramidal symptoms (EPS) like muscle stiffness and tremors, can also occur and require immediate medical attention. Therefore, regular monitoring and medical follow-up are crucial during treatment with metopimazine.

Overall, metopimazine represents a therapeutic option for managing psychotic disorders, offering relief from symptoms and improving quality of life for patients under its care. However, like any medication, its use should be carefully managed under the guidance of a qualified healthcare professional.

Metopimazine, a piperazine derivative primarily known for its antipsychotic properties, has also demonstrated efficacy in treating nausea and vomiting, particularly in specific clinical settings. Its antiemetic (anti-vomiting) action is attributed to its ability to block the receptors for dopamine and serotonin in the brain's chemoreceptor trigger zone (CTZ) and the gastrointestinal tract.

By inhibiting these receptors, metopimazine can reduce the sensation of nausea and prevent vomiting triggered by various stimuli, such as motion sickness, chemotherapy, and post-operative conditions. Its anti-dopaminergic effect is particularly significant in controlling nausea and vomiting associated with cancer treatments, where it can significantly improve patients' quality of life during their therapeutic journey.

Metopimazine's antiemetic properties make it a valuable addition to the arsenal of medications used to manage nausea and vomiting. However, its use should be carefully monitored due to potential side effects, including drowsiness, dizziness, and extrapyramidal symptoms. Therefore, it is essential to consult with a healthcare provider before initiating treatment with metopimazine for nausea and vomiting, to ensure safe and effective use.

In summary, metopimazine's antiemetic action provides a therapeutic option for managing nausea and vomiting, particularly in challenging clinical scenarios, enhancing patients' comfort and adherence to their treatment plans.

In the realm of drug synthesis, isonipecotamide has been extensively studied for its role in the preparation of 4-cyanopiperidine, a significant intermediate in the synthesis of both medicinally active ingredients and agrochemicals. 4-Cyanopiperidine itself serves as a key building block in the development of various pharmaceutical products, exhibiting drug efficacy in treating various conditions.

Several synthetic routes have been explored to convert it into 4-cyanopiperidine. One such method involves the dehydration using phosphorus oxychloride (POCl3), followed by a series of extraction and purification steps. Another approach utilizes trifluoroacetic anhydride or thionyl chloride for dehydration, often requiring additional steps such as hydrolysis or pH adjustment to yield the desired product. Despite these methods, challenges such as low yields, complex post-processing, and the use of hazardous chemicals persist.

One notable example of its application in drug synthesis is highlighted in patent documents, where that is transformed into 4-cyanopiperidine hydrochloride through a specific synthetic pathway. This process involves the dehydration with thionyl chloride in a suitable solvent, followed by pH adjustment and extraction to obtain the hydrochloride salt of 4-cyanopiperidine. This salt form is advantageous as it facilitates easier isolation and purification due to its reduced solubility compared to the free base.

In conclusion, it plays a crucial role in the synthesis of 4-cyanopiperidine, which in turn serves as a vital intermediate in the production of various therapeutically active compounds. Despite the challenges associated with its conversion into 4-cyanopiperidine, ongoing research continues to explore more efficient and environmentally friendly synthetic routes, aiming to optimize the production process and enhance the yield of this valuable intermediate.

Firstly, isonipecotamide possesses certain pharmacological properties that can be explored for therapeutic purposes. Although it is primarily used as a chemical intermediate, its structure and properties suggest potential interactions with biological systems. Research into its pharmacological activities could lead to the development of new medications or therapeutic approaches.

Secondly, as a chemical intermediate, it plays a crucial role in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows it to serve as a building block for the production of drugs that target specific biological pathways or receptors. This makes it an essential component in the drug discovery and development process.

Moreover, its biological activity may also extend to its ability to interact with certain enzymes or proteins within the body. These interactions could potentially regulate or modulate biological processes, making it a valuable tool in the study of cellular and molecular biology.

However, it's worth noting that the specific biological activities have not been fully characterized. Further research is needed to fully understand its potential therapeutic applications and any associated risks or side effects.

Isonipecotamide with its unique chemical structure and potential pharmacological properties, serves as an important intermediate in the pharmaceutical industry. Its biological activities, although not fully understood, hold promise for future therapeutic developments. As research progresses, we may discover new ways to harness its potential for treating various diseases and conditions.

Isonipecotamide is a versatile compound with applications spanning pharmacology, agrochemicals, and materials science. Its synthesis methods are evolving toward sustainability, while its pharmacological profile-particularly in opioid modulation and neuroprotection-offers promising therapeutic avenues. As the demand for safer analgesics, eco-friendly agrochemicals, and advanced materials grows, isonipecotamide will remain a critical building block. Future research should focus on green synthesis, drug repurposing, and nanoscale applications to unlock its full potential. By addressing challenges in toxicity, scalability, and cost, isonipecotamide will continue to drive innovations in health, agriculture, and technology.

► Drug Development
Dual-Action Agents: Combining isonipecotamide with serotonin reuptake inhibitors (SSRIs) for comorbid pain and depression.
Prodrugs: Ester derivatives (e.g., isonipecotamide acetate) improve oral bioavailability.
► Advanced Materials
Researchers are exploring isonipecotamide as a ligand in metal-organic frameworks (MOFs) for gas storage.

► Sustainable Synthesis
Biocatalytic routes using engineered E. coli strains to produce isonipecotamide from renewable feedstocks (e.g., glucose) are under development.

Isonipecotamide is a multifaceted compound with significant potential in pharmaceuticals, agrochemicals, and materials science. Its unique structure enables diverse chemical modifications, while advancements in green synthesis and biodegradability address environmental concerns. As industries prioritize sustainable and high-performance chemicals, isonipecotamide is poised to play a pivotal role in shaping the future of specialty chemistry and drug discovery.

Hot Tags: isonipecotamide cas 39546-32-2, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale, 2 1 1 2 1 2 1 2 1 quinquephenyl 4 yl 4 4 5 5 tetramethyl 1 3 2 dioxaborolane, 1 AMINO 2 NAPHTHOL 4 SULFONIC ACID, CAS 715 50 4, 1H Benzimidazole 1 4 bromophenyl 2 ethyl , CAS 19462 79 4, CAS 942615 32 9